Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T. Rowe Price Group | TROW | Sep 20, 2024 | 108.29 | -2.04 |
T. Rowe Price Growth Stock ETF | TGRW | Sep 20, 2024 | 37.45 | -0.25 |
T2 Biosystems | TTOO | Sep 20, 2024 | 2.19 | -0.45 |
Taboola.com | TBLA | Sep 20, 2024 | 3.25 | -0.31 |
Tactile Systems Technology | TCMD | Sep 20, 2024 | 14.17 | -0.49 |
Taitron Components A | TAIT | Sep 20, 2024 | 2.90 | +1.05 |
Taiwan Fund | TWN | Sep 20, 2024 | 43.70 | -1.91 |
Taiwan Index MSCI Ishares | EWT | Sep 20, 2024 | 53.16 | -1.02 |
Taiwan Semiconductor Manufacturing ADR | TSM | Sep 20, 2024 | 174.08 | -1.21 |
Take-Two Interactive Software | TTWO | Sep 20, 2024 | 148.78 | -3.18 |
Takeda Pharmaceutical ADR | TAK | Sep 20, 2024 | 14.80 | -0.87 |
TAL Education Group ADR | TAL | Sep 20, 2024 | 8.06 | -1.47 |
Talen Energy | TLN | Sep 20, 2024 | 184.09 | 0.00 |
Talis Biomedical | TLIS | Sep 20, 2024 | 4.38 | 0.00 |
Talkspace | TALK | Sep 20, 2024 | 2.19 | +4.29 |
Talos Energy | TALO | Sep 20, 2024 | 11.46 | -0.43 |
Talphera | TLPH | Sep 20, 2024 | 0.92 | -2.34 |
Tamboran Resources | TBN | Sep 20, 2024 | 20.25 | 0.00 |
Tandem Diabetes Care | TNDM | Sep 20, 2024 | 44.63 | +0.40 |
Tanger | SKT | Sep 20, 2024 | 31.91 | -0.13 |
Tango Therapeutics | TNGX | Sep 20, 2024 | 8.30 | -1.31 |
Tantech | TANH | Sep 20, 2024 | 0.16 | -1.66 |
Taoping | TAOP | Sep 20, 2024 | 0.57 | -0.07 |
Tapestry | TPR | Sep 20, 2024 | 42.57 | -0.58 |
Targa Resources | TRGP | Sep 20, 2024 | 152.83 | +0.41 |
Target | TGT | Sep 20, 2024 | 154.75 | -1.11 |
Target Global Acquisition I A | TGAA | Sep 20, 2024 | 11.26 | 0.00 |
Target Global Acquisition I Unit | TGAAU | Sep 20, 2024 | 11.29 | 0.00 |
Target Hospitality | TH | Sep 20, 2024 | 9.58 | -1.03 |
Tarsus Pharmaceuticals | TARS | Sep 20, 2024 | 34.51 | -0.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.